Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis
Lunedì 30 agosto 2021
circa 1 minuti di lettura
Journal and Affiliations:
European Heart Journal - Cardiovascular Pharmacotherapy, 30 agosto 2021
Marco Valgimigli, Cardiocentro Ticino, EOC, Lugano
Tags:
clopidogrel
de-escalation
dual antiplatelet therapy, acute coronary syndrome
P2Y12 inhibitor
prasugrel
ticagrelor
Authors:
Marco Valgimigli